ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.53

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$151,000

Balance Sheet

Total Assets

$51M

Total Liabilities

$75M

Stockholders' Equity

-$24M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20M	-$4M	-380.6%
Net Income	-$19M	-$5M	-286.8%

ARQT FY 2018 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena